Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.900
+0.005 (0.13%)
At close: Dec 5, 2025, 4:00 PM EST
3.920
+0.020 (0.51%)
After-hours: Dec 5, 2025, 4:10 PM EST

Athira Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
1623921204871,113
Upgrade
Market Cap Growth
-37.91%-75.47%-22.89%-75.36%-56.26%-
Upgrade
Enterprise Value
-9-45-79-99253887
Upgrade
Last Close Price
3.955.8724.3031.70130.30342.50
Upgrade
PB Ratio
0.580.510.710.511.524.06
Upgrade
P/TBV Ratio
0.580.510.710.511.524.06
Upgrade
Debt / Equity Ratio
0.030.030.010.010.010.00
Upgrade
Quick Ratio
9.053.905.179.4127.5642.22
Upgrade
Current Ratio
9.704.185.379.6828.0743.66
Upgrade
Return on Equity (ROE)
-89.42%-110.77%-64.42%-34.39%-18.43%-14.69%
Upgrade
Return on Assets (ROA)
-42.21%-55.23%-37.97%-19.91%-13.08%-8.87%
Upgrade
Return on Capital (ROIC)
-56.68%-68.02%-43.07%-20.98%-13.38%-9.12%
Upgrade
Return on Capital Employed (ROCE)
-144.10%-212.00%-96.70%-39.70%-19.80%-7.30%
Upgrade
Earnings Yield
-242.15%-427.29%-127.25%-79.75%-11.27%-1.79%
Upgrade
FCF Yield
-336.01%-428.45%-109.28%-61.38%-9.18%-2.38%
Upgrade
Buyback Yield / Dilution
-1.93%-1.21%-0.76%-2.20%-208.53%-235.50%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q